Overturning dogma to open the black box of DIPG

We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital. By Tom Ulrich You can't advance the care of a disease that you can't study. And for 40 years, that was the case with a rare, uniformly fatal pediatric brain tumor called diffuse intrinsic pontine glioma, or DIPG. Boston Children's HospitalNews Well, Vector Blog, Big Data, Blogread more
Source: Mass Device - Category: Medical Equipment Authors: Tags: Vector Blog Source Type: news